Home > Insider Trading > Filing (0000899243-20-004277)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1793294	Ppd Inc.	PPD	Services-Commercial Physical & Biological Research (8731)	453806427

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1801744	Glen Donovan	C/O Ppd, Inc. 929 North Front Street Wilmington NC 28401	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Non-Voting Common Stock	Disposition	2020-02-10	5,333	$0.00	0	No	4	D	Direct
Common Stock	Acquisiton	2020-02-10	5,333	$0.00	5,333	No	4	A	Direct
Common Stock	Acquisiton	2020-02-10	500	$27.00	5,833	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	D	Direct
No	4	A	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Non-Voting Common Stock	Stock Options (Right to Buy)	Acquisiton	2019-08-23	3,785	$0.00	3,785	$19.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,785		2029-08-23	No	4	A	Direct

Footnotes

Upon the completion of the initial public offering of PPD, Inc. (the "Issuer"), all shares of the Issuer's non-voting common stock automatically converted into shares of the Issuer's voting common stock on a one-for-one basis.
Shares were acquired in a directed share program in connection with the Issuer's initial public offering.
Represents stock options previously granted to the reporting person on August 23, 2019. These stock options were already reflected on the reporting person's previously filed Form 3.
Represents 3,785 stock options which are unvested and will vest in equal annual installments on August 23, 2020, August 23, 2021, August 23, 2022, August 23, 2023 and August 23, 2024. Does not include an additional 3,785 stock options with an exercise price of $19.24 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2019-2023.